Search Results for ""drugs for""
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for "drugs for". Results 2491 to 2500 of 2585 total matches.

Laser Treatment of Onychomycosis

   
The Medical Letter on Drugs and Therapeutics • Feb 18, 2013  (Issue 1410)
The Medical Letter® On Drugs and Therapeutics Volume 55 (Issue 1410) February 18, 2013 ...
Fungal infections of the fingernails or toenails can persist for months or years despite topical and systemic antimicrobial therapy. The FDA has cleared several short-pulse laser systems for treatment of this mainly cosmetic disorder.
Med Lett Drugs Ther. 2013 Feb 18;55(1410):15 |  Show IntroductionHide Introduction

MiniMed 530G: An Insulin Pump with Low-Glucose Suspend Automation

   
The Medical Letter on Drugs and Therapeutics • Dec 09, 2013  (Issue 1431)
The Medical Letter® On Drugs and Therapeutics Volume 55 (Issue 1431) December 9, 2013 Published ...
The FDA has approved the MiniMed 530G (Medtronic), an insulin pump used in combination with a continuous glucose monitoring sensor (Enlite) that can stop delivery of insulin when interstitial glucose reaches a prespecified low level. It is the only sensoraugmented insulin pump available in the US with this capability.
Med Lett Drugs Ther. 2013 Dec 9;55(1431):97-8 |  Show IntroductionHide Introduction

Low-Dose Aspirin for Prevention of Preeclampsia

   
The Medical Letter on Drugs and Therapeutics • Jun 23, 2014  (Issue 1445)
The Medical Letter® On Drugs and Therapeutics Published by The Medical Letter, Inc. • 145 ...
The American College of Obstetricians and Gynecologists (ACOG) and the US Preventive Services Task Force (USPSTF) have recommended that women at risk for preeclampsia take low-dose aspirin daily after the first trimester.
Med Lett Drugs Ther. 2014 Jun 23;56(1445):49 |  Show IntroductionHide Introduction

In Brief: Midostaurin (Rydapt) for AML and Advanced Systemic Mastocytosis (online only)

   
The Medical Letter on Drugs and Therapeutics • Aug 14, 2017  (Issue 1527)
with permission by First Databank, Inc. All rights reserved. ©2017. www.fdbhealth.com/policies/drug-pricing ...
The FDA has approved the oral multikinase inhibitor midostaurin (Rydapt – Novartis) for first-line treatment, in addition to standard chemotherapy, of adults with FLT3 (fms-like tyrosine kinase 3) mutation-positive acute myeloid leukemia (AML). About 30% of patients with AML have FLT3 mutations. Midostaurin is also approved as a single agent for treatment of adults with aggressive systemic mastocytosis, systemic mastocytosis with associated hematological neoplasm, or mast-cell leukemia. In mastocytosis, midostaurin targets mutant c-KIT, not FLT3.In a randomized, double-blind trial, 717...
Med Lett Drugs Ther. 2017 Aug 14;59(1527):e140 |  Show IntroductionHide Introduction

In Brief: Dapagliflozin (Farxiga) for Chronic Kidney Disease

   
The Medical Letter on Drugs and Therapeutics • Jul 26, 2021  (Issue 1629)
. All rights reserved. ©2021. www.fdbhealth. com/policies/drug-pricing-policy. chronic kidney disease Forxiga ...
The sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin (Farxiga – AstraZeneca) has been approved by the FDA for treatment of adults with chronic kidney disease (CKD) at risk of progression (not defined in the label). Dapagliflozin is the first SGLT2 inhibitor to be approved in the US for treatment of CKD.
Med Lett Drugs Ther. 2021 Jul 26;63(1629):115 |  Show IntroductionHide Introduction

Sunscreens

   
The Medical Letter on Drugs and Therapeutics • Jul 26, 2021  (Issue 1629)
. All rights reserved. ©2021. www.fdbhealth. com/policies/drug-pricing-policy. sunscreens Insect repellents ...
Excessive exposure to ultraviolet (UV) radiation is associated with sunburn, photoaging, and skin cancer. Sunscreens are widely used to reduce these risks, but questions remain about their effectiveness and safety. The FDA has issued a proposed rule that would require manufacturers to perform additional safety studies for some sunscreen active ingredients and would mandate better UVA protection in sunscreen products. Some sunscreen products containing FDA-approved active ingredients are listed in Table 2.
Med Lett Drugs Ther. 2021 Jul 26;63(1629):115-20 |  Show IntroductionHide Introduction

In Brief: Doxycycline for STI Post-Exposure Prophylaxis

   
The Medical Letter on Drugs and Therapeutics • Jul 22, 2024  (Issue 1707)
of the drug could increase the incidence of nasal colonization with tetracycline-resistant Staphylococcus ...
The CDC has issued a recommendation for use of a single dose of doxycycline for post-exposure prophylaxis (PEP) of bacterial sexually transmitted infections (STIs), specifically syphilis, chlamydia, and gonorrhea, in men who have sex with men (MSM) and transgender women (TGW) who had a bacterial STI within the previous 12 months.
Med Lett Drugs Ther. 2024 Jul 22;66(1707):119-20   doi:10.58347/tml.2024.1707f |  Show IntroductionHide Introduction

Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Chronic Weight Management (online only)

   
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024  (Issue 1708)
pancreatitis and acute gall bladder disease Drug Eligible Patients Usual Dosage Other Information GLP-1 ...
View the Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Chronic Weight Management
Med Lett Drugs Ther. 2024 Aug 5;66(1708):e1-2   doi:10.58347/tml.2024.1708d |  Show IntroductionHide Introduction

Dexamethasone Bacterial Meningitis In Children

   
The Medical Letter on Drugs and Therapeutics • Jan 27, 1989  (Issue 784)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
A recent report in the New England Journal of Medicine suggested that in children with bacterial meningitis, adding the corticosteroid dexamethasone (Decadron; and others) to antibiotic treatment could decrease the incidence of moderate or severe hearing loss.
Med Lett Drugs Ther. 1989 Jan 27;31(784):6-7 |  Show IntroductionHide Introduction

Balloon Dilatation Of The Prostate

   
The Medical Letter on Drugs and Therapeutics • Jun 29, 1990  (Issue 821)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
To avoid the morbidity and occasional mortality of transurethral resection or open prostatectomy, some urologists are now using balloon dilatation of the prostatic urethra to treat benign prostatic hypertrophy.
Med Lett Drugs Ther. 1990 Jun 29;32(821):64 |  Show IntroductionHide Introduction